Get started
Author

Robert K. Hofbauer

Observed names: Hofbauer, Robert Kenneth., R. K. Hofbauer, R.K. Hofbauer, Robert Hofbauer, Robert K Hofbauer, Robert K. Hofbauer
Observed institutions: Acadia Pharmaceuticals (United States), Montreal Neurological Institute and Hospital, Sahlgrenska University Hospital, Allergan (United States), Forest Laboratories (United States), McGill University, Université de Montréal
ORCID: 0009-0005-5568-8759
Observed ORCID: 0009-0005-5568-8759
OpenAlex ID: A5063262312
Pain perception: Is there a role for primary somatosensory cortex?
1999 · M. C. Bushnell, G. H. Duncan, et al. · Proceedings of the National Academy of Sciences · 763
Cortical Representation of the Sensory Dimension of Pain
2001 · Robert K. Hofbauer, Pierre Rainville, et al. · Journal of Neurophysiology · 632
Dissociation of sensory and affective dimensions of pain using hypnotic modulation
1999 · Pierre Rainville, Benoît Carrier, et al. · Pain · 549
Cerebral Mechanisms of Hypnotic Induction and Suggestion
1999 · Pierre Rainville, Robert K. Hofbauer, et al. · Journal of Cognitive Neuroscience · 475
Hypnosis Modulates Activity in Brain Structures Involved in the Regulation of Consciousness
2002 · Pierre Rainville, Robert K. Hofbauer, et al. · Journal of Cognitive Neuroscience · 344
Dose-dependent Effects of Propofol on the Central Processing of Thermal Pain
2004 · Robert K. Hofbauer, Pierre Fiset, et al. · Anesthesiology · 93
PDF
Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis
2015 · Alireza Atri, Suzanne B Hendrix, et al. · Alzheimer s Research & Therapy · 78
PDF
Magnetic resonance imaging and neuropsychological results from a trial of memantine in Alzheimer's disease
2011 · Michael W. Weiner, Carl Sadowsky, et al. · Alzheimer s & Dementia · 39
Thermal and Tactile Sensory Deficits and Allodynia in a Nerve-Injured Patient: A Multimodal Psychophysical and Functional Magnetic Resonance Imaging Study
2005 · Robert K Hofbauer, Håkan W Olausson, et al. · Clinical Journal of Pain · 31
Memantine and Functional Communication in Alzheimer's Disease: Results of a 12-Week, International, Randomized Clinical Trial
2012 · Judith Saxton, Robert K. Hofbauer, et al. · Journal of Alzheimer s Disease · 26
PDF
A Novel Once-Daily Fixed-Dose Combination of Memantine Extended Release and Donepezil for the Treatment of Moderate to Severe Alzheimer’s Disease: Two Phase I Studies in Healthy Volunteers
2015 · Ramesh Boinpally, Laishun Chen, et al. · Clinical Drug Investigation · 23
PDF
Effects of memantine treatment on language abilities and functional communication: A review of data
2013 · Michael Tocco, Kathryn Bayles, et al. · Aphasiology · 17
Memantine Discontinuation and the Health Status of Nursing Home Residents With Alzheimer's Disease
2010 · Howard Fillit, Robert K. Hofbauer, et al. · Journal of the American Medical Directors Association · 16
Human functional brain imaging
1999 · M. Catherine Bushnell, Gary H. Duncan, et al. · Pain Forum · 5
P4‐352: Area Under the Curve (auc) Pooled Analysis of Four Randomized Clinical Trials Shows Cumulative Benefits of Memantine‐donepezil Combination Over Component Monotherapies Across Clinical Domains in Alzheimer's Dementia
2014 · Alireza Atri, Suzanne Hendrix, et al. · Alzheimer s & Dementia · 4
P1‐370: Efficacy and Tolerability of Memantine Extended Release Added to Stable Donepezil Regimen in Individuals With Moderate to Severe Alzheimer's Disease: Subset Analysis of a Randomized Clinical Trial
2014 · George Grossberg, Gustavo Alva, et al. · Alzheimer s & Dementia · 4
P1‐271: Effects of memantine on functional communication in patients with moderate AD: Results of a 12‐week placebo‐controlled trial
2009 · Robert K. Hofbauer, Judith Saxton, et al. · Alzheimer s & Dementia · 4
Efficacy and Tolerability of Memantine Extended Release Added to Stable Donepezil Regimen in Individuals with Moderate to Severe Alzheimer’s Disease: Subset Analysis of a Randomized Clinical Trial (P7.101)
2015 · George Grossberg, Gustavo Alva, et al. · Neurology · 2
P1‐462: Memantine and prevention of worsening in functional communication: Post hoc analysis of a randomized, placebo‐controlled trial in patients with moderate Alzheimer's disease
2010 · Robert K. Hofbauer, Michael Tocco, et al. · Alzheimer s & Dementia · 2
P4‐356: Benefits of Early Versus Delayed Memantine Addition to Donepezil Monotherapy in Patients With Moderate to Severe Alzheimer's Disease: a Pooled Analysis of Two Randomized Trials
2014 · Stephen M. Graham, Suzanne Hendrix, et al. · Alzheimer s & Dementia · 1
P1‐446: Memantine and prevention of worsening across multiple domains: Post hoc analysis of a randomized, placebo‐controlled trial in patients with moderate Alzheimer's disease
2010 · Michael L. Miller, Michael Tocco, et al. · Alzheimer s & Dementia · 1
P.5.a.008 Effects of memantine on functional communication in moderate Alzheimer's disease: results of a 12-week placebo-controlled trial
2009 · S. Graham, J. Saxton, et al. · European Neuropsychopharmacology · 1
P3‐483: Memantine discontinuation in nursing home residents with Alzheimer's disease was associated with an increase in Alzheimer's disease symptoms
2008 · Constantine Lyketsos, Howard Fillit, et al. · Alzheimer s & Dementia · 1
Discontinuation of Memantine Therapy in Nursing Home Residents With Alzheimer’s Disease is Associated With Increased Utilization of Psychotropic Medications and Decreased Body Weight
2008 · Howard Fillit, Robert K. Hofbauer, et al. · Journal of the American Medical Directors Association · 1
Differential rCBF changes in ACC during Pain and Hypnosis
1998 · R.K. Hofbauer, P. Rainville, et al. · NeuroImage · 1
Works count: 38
Citation count: 3,113
H-index: 13
I10-index: 13
Year
Topic
Type